AIM ImmunoTech Inc [AMEX: AIM] surged by $0.07 during the normal trading session on while it closed the day at $0.45.
AIM ImmunoTech Inc stock has also gained 22.87% of its value over the past 7 days. However, AIM stock has inclined by 16.15% in the 3 months of the year. Over the past six months meanwhile, it has lost -5.73% and gained 1.39% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for AIM stock reached $25.48 million, with 57.14 million shares outstanding and 51.89 million shares in the current float. Compared to the average trading volume of 253.77K shares, AIM reached a trading volume of 2836961 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about AIM ImmunoTech Inc [AIM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AIM shares is $3.58 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AIM stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for AIM ImmunoTech Inc is set at 0.05, with the Price to Sales ratio for AIM stock in the period of the last 12 months amounting to 134.13. The Price to Book ratio for the last quarter was 5.42, with the Price to Cash per share for the same quarter was set at 0.19.
AIM stock trade performance evaluation
AIM ImmunoTech Inc [AIM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 22.87. With this latest performance, AIM shares gained by 4.94% in over the last four-week period, additionally sinking by -5.73% over the last 6 months – not to mention a drop of -3.04% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AIM stock in for the last two-week period is set at 59.96, with the RSI for the last a single of trading hit 67.93, and the three-weeks RSI is set at 55.76 for AIM ImmunoTech Inc [AIM]. The present Moving Average for the last 50 days of trading for this stock 0.4340, while it was recorded at 0.3834 for the last single week of trading, and 0.4612 for the last 200 days.
AIM ImmunoTech Inc [AIM]: An insightful look at the core fundamentals
AIM ImmunoTech Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.14 and a Current Ratio set at 1.14.
Earnings per share (EPS) analysis for AIM ImmunoTech Inc [AIM] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AIM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for AIM ImmunoTech Inc go to 25.00%.
AIM ImmunoTech Inc [AIM]: Institutional Ownership
The top three institutional holders of AIM stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in AIM stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in AIM stock with ownership which is approximately 5.8386%.
